Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial

Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial

Autism spectrum disorder (ASD) is a rapidly growing neurodevelopmental disorder. Both probiotics and oxytocin were reported to have therapeutic potential; however, the combination therapy has not yet been studied. We conducted a randomized, double-blinded, placebo-controlled, 2-stage pilot trial in...

Full description

Bibliographic Details
Main Authors: Xue-Jun Kong, Jun Liu, Kevin Liu, Madelyn Koh, Hannah Sherman, Siyu Liu, Ruiyi Tian, Piyawat Sukijthamapan, Jiuju Wang, Michelle Fong, Lei Xu, Cullen Clairmont, Min-Seo Jeong, Alice Li, Maria Lopes, Veronica Hagan, Tess Dutton, Suk-Tak (Phoebe) Chan, Hang Lee, Amy Kendall, Kenneth Kwong, Yiqing Song
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Nutrients
Subjects:
autism spectrum disorder (ASD)
probiotics
oxytocin
microbiome
inflammation markers
Online Access:https://www.mdpi.com/2072-6643/13/5/1552

Internet

https://www.mdpi.com/2072-6643/13/5/1552

Similar Items